Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MAb to erbB-2, HER2/neu | Login | MAb to erbB-2, HER2/neu | ||||||||||||||||
|
||||||||||||||||||
MAb to erbB-2, HER2/neu | Login | MAb to erbB-2, HER2/neu | ||||||||||||||||
|
||||||||||||||||||
MAb to Cyfra-21-1, Keratin K19 | Login | MAb to Cyfra-21-1, Keratin K19 | ||||||||||||||||
|
||||||||||||||||||
MAb to MUC1 (CA 27.29) | Login | MAb to MUC1 (CA 27.29) | ||||||||||||||||
|
||||||||||||||||||
MAb to Cancer Antigen CA 19-9 | Login | MAb to Cancer Antigen CA 19-9 | ||||||||||||||||
|
||||||||||||||||||
MAB TO PSMA | Login | MAB TO PSMA | ||||||||||||||||
|
||||||||||||||||||
MAB TO LAMIN (MIXED) | Login | MAB TO LAMIN (MIXED) | ||||||||||||||||
|
||||||||||||||||||
RABBIT ANTI CYCLIN E | Login | RABBIT ANTI CYCLIN E | ||||||||||||||||
|
||||||||||||||||||
MAb TO PSA TOTAL | Login | MAb TO PSA TOTAL | ||||||||||||||||
|
||||||||||||||||||
MAb TO PSA FREE | Login | MAb TO PSA FREE | ||||||||||||||||
|
||||||||||||||||||
Mab to Stat5, Ptyr 694/699 | Login | Mab to Stat5, Ptyr 694/699 | ||||||||||||||||
|
||||||||||||||||||
MAB TO NEURON SPECIFIC ENOLASE | Login | MAB TO NEURON SPECIFIC ENOLASE | ||||||||||||||||
|
||||||||||||||||||
MAB TO MUC1 (CA15-3) | Login | MAB TO MUC1 (CA15-3) | ||||||||||||||||
|
||||||||||||||||||
MAB TO PSA, TOTAL | Login | MAB TO PSA, TOTAL | ||||||||||||||||
|
||||||||||||||||||
MAB TO MUC1 (CA15-3) | Login | MAB TO MUC1 (CA15-3) | ||||||||||||||||
|
||||||||||||||||||
MAB TO HUMAN ALPHA FETOPROTEIN | Login | MAB TO HUMAN ALPHA FETOPROTEIN | ||||||||||||||||
|
||||||||||||||||||
MAB TO CA125 GROUP A | Login | MAB TO CA125 GROUP A | ||||||||||||||||
|
||||||||||||||||||
MAB TO PSA, Free | Login | MAB TO PSA, Free | ||||||||||||||||
|
||||||||||||||||||
MAB TO NEURON SPECIFIC ENOLASE | Login | MAB TO NEURON SPECIFIC ENOLASE | ||||||||||||||||
|
||||||||||||||||||
MAB TO CA125 GROUP B | Login | MAB TO CA125 GROUP B | ||||||||||||||||
|
||||||||||||||||||
MAB TO PSA, TOTAL | Login | MAB TO PSA, TOTAL | ||||||||||||||||
|
||||||||||||||||||
MAb to Human Alpha Fetoprotein | Login | MAb to Human Alpha Fetoprotein | ||||||||||||||||
|
||||||||||||||||||
MAb to CA125, Group B | Login | MAb to CA125, Group B | ||||||||||||||||
|
||||||||||||||||||
MAB TO CA125, GROUP B | Login | MAB TO CA125, GROUP B | ||||||||||||||||
|
||||||||||||||||||
MAB TO C-MYC | Login | MAB TO C-MYC | ||||||||||||||||
|